The Valley Desk

Clinical trial reportInflammatory bowel diseasesPublished

Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Inflammatory bowel diseases
Published
Subject terms
Humans; Crohn Disease; Treatment Outcome; Remission Induction; Severity of Illness Index; Double-Blind Method; Adult; Middle Aged; Female; Male; Young Adult; Administration, Intravenous
PubMed ID
40971924
PubMed Central ID
PMC12688074
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal